Quantum BioPharma Ltd.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| QNTM | JUNS | SILO | NRSN | ENVB | PMN | |
|---|---|---|---|---|---|---|
| Market cap | 18.13M | 4.01M | 3.06M | 6.60M | 6.58M | 84.74M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -0.4 | 50.7 | -2.1 | -0.5 | -1.0 | -2.1 |
| Price/book | 2.7 | -5.5 | 0.3 | -3.6 | 0.7 | 1.7 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −80.65% | −97.38% | −84.39% | −85.00% | −81.30% | −19.92% |
| Today | −4.08% | +6.67% | +1.36% | −4.92% | +1.38% | −1.66% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All QNTM news ›Quantum BioPharma Ltd. (NASDAQ: QNTM) Enters Study Start-Up Agreement for Lucid-MS Phase 2 Trial
Pune, India, October 6th, 2026, FinanceWire This is a paid advertisement. The Phase 2 trial will evaluate the efficacy, safety and tolerability of Lucid-MS in people with progressive forms of MS. The randomized, double-blind,…
Quantum BioPharma (NASDAQ: QNTM) gets consolidation in market-manipulation suit
Posted by Danessa Lincoln on Oct 8th, 2026 Quantum BioPharma Ltd. (NASDAQ: QNTM) said on Oct. 08, 2026 that a court consolidated two lawsuits over alleged share manipulation. The U.S. District Court for the Southern District of New York…
Grant & Eisenhofer Appointed Lead Counsel in Lawsuit Alleging CIBC and RBC Manipulated Quantum BioPharma Stock
TradingView Grant & Eisenhofer Appointed Lead Counsel in Lawsuit Alleging CIBC and RBC Manipulated Quantum BioPharma Stock Pune, India, October 8th, 2026, FinanceWire Quantum BioPharma Ltd. The Quantum Biopharma lawsuit alleged that…
Net debt of Quince Therapeutics, Inc. – NASDAQ:IRLA
Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in unlocking the power of a patient’s biology for the treatment of rare diseases. Its product includes eDSP, developed using their proprietary Autologous Intracellular…
Quantum BioPharma, Thermo Fisher Partner on Phase 2 Multiple Sclerosis Trial
Quantum BioPharma has signed a Study Start-Up Agreement with Thermo Fisher Scientific's clinical research business to support the implementation of its Phase 2 Lucid-21-302, or Lucid-MS, trial... Thermo Fisher Scientific, Inc. Advanced…
EXCLUSIVE: Thermo Fisher To Support Quantum Biopharma in Progressive Multiple Sclerosis Drug Trial
Quantum BioPharma Ltd. (NASDAQ:QNTM) on Tuesday said it is partnering with the clinical research division of Thermo Fisher Scientific Inc.(NYSE:TMO) to launch a Phase 2 clinical trial for its multiple sclerosis treatment, Lucid-MS. The…
Quantum BioPharma signs Thermo Fisher contract for Phase 2 MS trial
Quantum said on Oct. 6 it had entered a Study Start-Up Agreement; it gave no first-dose or readout date. In its Oct. 6 release, Quantum called the contract a Study Start-Up Agreement. Thermo Fisher's PPD clinical research business will…
Quantum BioPharma Signs Contract with Thermo Fisher Scientific’s Clinical Research Business to Implement Phase 2 Lucid-MS Trial in Multiple Sclerosis
This press release is provided by GlobeNewswire and is published as received. The execution of the contract represents an important milestone in the clinical development of Lucid-MS and marks the initiation of formal study start-up…
Karyopharm: Anders Hove reports 4.5% ownership
Two Acorn funds account for one manager’s reported stake in Karyopharm (KPTI). Stock Titan - [SCHEDULE 13G/A] Karyopharm Therapeutics Inc. Amended Passive Investment Disclosure Karyopharm: Anders Hove reports 4.5% ownership Reported…
Quantum BioPharma signs Phase 2 Lucid-MS trial deal
The planned study will assess Lucid-MS in progressive MS using clinical and radiological endpoints. Quantum BioPharma Ltd. (QNTM) entered into a Study Start-Up Agreement with Thermo Fisher Scientific’s clinical research business to…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
stocktitan.net7
-
tradingview.com4
-
themarketsdaily.com2
-
aol.com1
-
bnnbloomberg.ca1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 23 articles, not a forecast.